Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,427 signal articles · 135 in last 24h · 153,916 total before filter · latest 1h ago
135last 24h
866last 7d
142● bullish (7d)
100● bearish (7d)
214publishers
AllMacro208Earnings103M&A123Regulatory22Product21Analyst14
✕ clear all filtersticker: ELSentiment:bullishneutralbearishshow all (incl. clickbait)
Fed is set for first rate hike in three years
Yahoo Finance Video9d agoneutralVIDEO
Fed is set for first rate hike in three years

Scott Melker discusses the odds of the Federal Reserve hiking interest rates at the central bank's September FOMC meeting on Wednesday. This could be the first time Fed officials raise rates since 2023. "The Daily Wolf with Scott Melker" airs every day at 12:00 p.m. Tune in for your daily dose of all things crypto.

Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings | Stock Movers
Bloomberg36d agobullishVIDEO
Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings | Stock Movers

On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate.

Estée Lauder shares surge on earnings beat, raised margin guidance
Proactive36d agobullish
Estée Lauder shares surge on earnings beat, raised margin guidance

Estee Lauder Companies Inc (NYSE:EL, XETRA:ELAA) shares jumped more than 15% on Wednesday after the beauty group posted fourth-quarter results that beat Wall Street estimates and raised its profit margin outlook for fiscal 2027. The company reported revenue of $3.6 billion for its fiscal...

Estee Lauder Companies Q4 Earnings Call Highlights
MarketBeat36d agoneutral
Estee Lauder Companies Q4 Earnings Call Highlights

Estee Lauder Companies (NYSE:EL) said fiscal 2026 marked a return to growth and a substantial improvement in profitability as the prestige beauty company advanced its Beauty Reimagined strategy and Profit Recovery and Growth Plan. For the full fiscal year, reported sales rose 5% and organic sales i

Estée Lauder Stock Surges as Earnings Show Growth Plan Is Working
Barrons.com36d agobullish
Estée Lauder Stock Surges as Earnings Show Growth Plan Is Working

Shares of Estée Lauder advanced on Wednesday as the beauty and cosmetics giant’s better-than-expected quarterly earnings showed Wall Street its growth plan is well underway. The company announced adjusted earnings of 39 cents a share in the fiscal fourth quarter, up from 9 cents a year ago and above Wall Street’s expectation of 32 cents. Estée Lauder reported adjusted earnings of $2.51 a share for the full fiscal year, up from $1.51 last year.

Estee Lauder Narrows Loss as Sales Climb
The Wall Street Journal36d agoneutral
Estee Lauder Narrows Loss as Sales Climb

The Estee Lauder Companies narrowed its fiscal fourth-quarter loss on higher sales, as the company’s turnaround continued to pick up steam.

Estée Lauder stock jumps as sales beat estimates
Bloomberg36d agobullish
Estée Lauder stock jumps as sales beat estimates

Estée Lauder Cos. posted quarterly results that beat estimates and ended a run of three straight declines in annual revenue, a sign the beauty conglomerate's turnaround efforts are gaining momentum.